zalcitabine has been researched along with Psoriasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berthelot, P; Frésard, A; Guglielminotti, C; Lucht, F; Perrot, JL | 1 |
| Fischer, T; Ramadori, G; Reich, K; Schwörer, H; Vente, C | 1 |
2 other study(ies) available for zalcitabine and Psoriasis
| Article | Year |
|---|---|
Dramatic cutaneous psoriasis improvement in a patient with the human immunodeficiency virus treated with 2',3'-dideoxy,3'-thyacytidine [correction of 2',3'-dideoxycytidine] and ritonavir.
Topics: Adult; Anti-HIV Agents; HIV Seropositivity; Humans; Male; Psoriasis; Remission Induction; Ritonavir; Zalcitabine | 1997 |
Clinical improvement of HIV-associated psoriasis parallels a reduction of HIV viral load induced by effective antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Male; Psoriasis; Reverse Transcriptase Inhibitors; Viral Load; Zalcitabine; Zidovudine | 1999 |